In this episode of clinpharmpod, Dr. Avery McIntosh shares his thoughts on CPT’s new call for papers for a themed issue on quantitative clinical pharmacology for evidence generation and next-generation drug development. He and host Alaina Webster discuss the need for better cross-discipline alignment among statistics, clinical pharmacology, pharmacometrics, QSP, and regulatory science; areas of interest including model-informed drug development, innovative trial designs, real-world evidence and causal inference, AI/ML and hybrid models, federated learning, advanced therapeutics, and plausible mechanism pathways and new approach methodologies (NAMs). Submissions are due October 31, 2026. You can find more information about this call for papers here.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related